Microsoft’s Understated Role in OGM When pe
Post# of 82

When people talk about Bionano Genomics, they usually focus on things like FDA approval, new diagnostic tests, or how it’s changing the way genetic diseases are diagnosed. But behind the scenes, one of the biggest names in tech is quietly making it all run smoother… Microsoft.
Back in 2021, Bionano teamed up with Microsoft to help tackle a big challenge, how to process massive amounts of genetic data quickly and efficiently. Instead of relying solely on their own computing power, Bionano tapped into Microsoft’s cloud platform. That move cut their analysis time by nearly a third and saved them more than half of their compute costs. For researchers and doctors, that means faster answers and lower costs, which can translate to better care for patients.
This collaboration hasn’t been widely talked about, but it’s making a real difference. Microsoft’s cloud tech helps Bionano scale its reach, whether it’s analyzing complex genetic conditions or preparing for broader clinical use. While other headlines focus on market speculation and clinical milestones, this partnership is quietly helping Bionano become a more efficient and reliable player in the world of medical diagnostics.
Microsoft may not be in the spotlight here, but their tools are powering real change behind the scenes.
Bionano Genomics’ acquires, affiliations & partnerships: Microsoft, BioDiscovery, Diagens, Lineagen, Revvity, Hamilton, and Tecan. I think I have all of them?
BNGO $3.40

